SYK
SYK
US8636671013
Stryker Corporation
Loading chart...

Company Profile

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke and venous thromboembolism; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

Latest News

Related stocks

ABT
ABT • United States
Abbott Laboratories
99.6 USD
173.48B USD 1Y -26.6%
BSX
BSX • United States
Boston Scientific Corporation
42.73 USD
61.93B USD 1Y -56.6%
EW
EW • United States
Edwards Lifesciences Corporatio
85.21 USD
49.06B USD 1Y +11.2%
GEHC
GEHC • United States
GE HealthCare Technologies Inc.
65.74 USD
29.9B USD 1Y -14.5%
STE
STE • United States
STERIS plc (Ireland)
214.4 USD
20.9B USD 1Y -13%
DXCM
DXCM • United States
DexCom, Inc.
84.11 USD
31.74B USD 1Y +24.5%
PEN
PEN • United States
Penumbra, Inc.
319.4 USD
12.58B USD 1Y +22.6%
ZBH
ZBH • United States
Zimmer Biomet Holdings, Inc.
89.14 USD
17B USD 1Y -9.6%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
25.7% p.a.
Max Drawdown (5Y)
-33.1%
Sharpe Ratio (5Y)
-0.06
Beta Factor
0.78
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
ende